CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.00
-0.50 (-4.76%)
Jun 16, 2026, 8:43 AM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 5.69 million as of June 16, 2026. Its market cap has decreased by -8.28% in one year.
Market Cap
5.69M
Enterprise Value
5.35M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 5.69M, a decrease of -79.83%. That is a compound annual growth rate of -7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 5.69M | 10.07% |
| Dec 31, 2025 | 5.17M | 43.93% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 16.83M |
| Fusion Antibodies | 15.00M |
| Cizzle Biotechnology Holdings | 13.39M |
| Genflow Biosciences | 12.04M |
| Oxford BioDynamics | 7.72M |
| OptiBiotix Health | 6.40M |
| Nuformix | 5.35M |
| Theracryf | 5.05M |